In trading on Tuesday, shares of Ligand Pharmaceuticals Inc (Symbol: LGND) crossed below their 200 day moving average of $105.35, changing hands as low as $105.02 per share. Ligand Pharmaceuticals ...
JUPITER, Fla., March 03, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that Chief Executive Officer Todd Davis and Chief Financial Officer Tavo ...
In a report released today, Balaji Prasad from Barclays maintained a Buy rating on Ligand Pharma (LGND – Research Report), with a price target of $160.00. The company’s shares closed last ...
In a report released today, Balaji Prasad from Barclays maintained a Buy rating on Ligand Pharma (LGND – Research Report), with a price target of $160.00. The company’s shares closed yesterday ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results